O	O	O	0	15	Immortalization	Immortalization	B-NP	NN	O	0	ROOT	O
O	O	O	16	18	of	of	B-PP	IN	O	1	NMOD	O
T1	B-Protein	B-Protein	19	22	CD4	CD4	B-NP	NN	B-cell_type	13	NMOD	B-cell_type
O	O	O	22	23	(	(	O	(	I-cell_type	6	DEP	I-cell_type
O	O	O	23	24	+	+	B-NP	SYM	I-cell_type	6	DEP	I-cell_type
O	O	O	24	25	)	)	O	)	I-cell_type	3	NMOD	I-cell_type
O	O	O	26	29	and	and	O	CC	I-cell_type	13	NMOD	I-cell_type
O	O	O	30	33	CD8	CD8	B-NP	NN	I-cell_type	13	NMOD	I-cell_type
O	O	O	33	34	(	(	O	(	I-cell_type	11	DEP	I-cell_type
O	O	O	34	35	+	+	O	SYM	I-cell_type	11	DEP	I-cell_type
O	O	O	35	36	)	)	O	)	I-cell_type	8	NMOD	I-cell_type
O	O	O	37	38	T	T	B-NP	NN	I-cell_type	13	NMOD	I-cell_type
O	O	O	39	50	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	O	51	53	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	54	59	human	human	B-NP	JJ	O	14	PMOD	O
O	O	O	60	61	T	T	I-NP	NN	O	24	NMOD	O
O	O	O	61	62	-	-	I-NP	HYPH	O	24	P	O
O	O	O	62	66	cell	cell	I-NP	NN	O	24	NMOD	O
O	O	O	67	75	leukemia	leukemia	I-NP	NN	O	24	NMOD	O
O	O	O	76	81	virus	virus	I-NP	NN	O	24	NMOD	O
O	O	O	82	86	type	type	I-NP	NN	O	24	NMOD	O
O	O	O	87	88	1	1	I-NP	CD	O	24	NMOD	O
T2	B-Protein	B-Protein	89	92	Tax	Tax	I-NP	NN	B-protein	24	NMOD	B-protein
O	O	O	93	100	mutants	mutant	I-NP	NNS	I-protein	15	NMOD	I-protein
O	O	O	101	110	expressed	express	B-VP	VBN	O	15	NMOD	O
O	O	O	111	113	in	in	B-PP	IN	O	25	VMOD	O
O	O	O	114	115	a	a	B-NP	DT	O	30	NMOD	O
O	O	O	116	126	functional	functional	I-NP	JJ	B-cell_line	30	NMOD	B-cell_line
O	O	O	127	136	molecular	molecular	I-NP	JJ	I-cell_line	30	NMOD	I-cell_line
O	O	O	137	142	clone	clone	I-NP	NN	I-cell_line	26	PMOD	I-cell_line
O	O	O	142	143	.	.	O	.	O	1	P	O

O	O	O	145	148	The	The	B-NP	DT	O	8	NMOD	O
O	O	O	149	154	human	human	I-NP	JJ	O	8	NMOD	O
O	O	O	155	156	T	T	I-NP	NN	O	8	NMOD	O
O	O	O	156	157	-	-	I-NP	HYPH	O	8	NMOD	O
O	O	O	157	161	cell	cell	I-NP	NN	O	8	NMOD	O
O	O	O	162	170	leukemia	leukemia	I-NP	NN	O	8	NMOD	O
O	O	O	171	176	virus	virus	I-NP	NN	O	8	NMOD	O
O	O	O	177	181	type	type	I-NP	NN	O	19	NMOD	O
O	O	O	182	183	1	1	I-NP	CD	O	8	NMOD	O
O	O	O	184	185	(	(	O	(	O	14	DEP	O
O	O	O	185	189	HTLV	HTLV	B-NP	NN	O	13	SUB	O
O	O	O	189	190	-	-	B-NP	HYPH	O	13	P	O
O	O	O	190	191	1	1	I-NP	CD	O	14	DEP	O
O	O	O	191	192	)	)	O	)	O	8	NMOD	O
O	O	O	193	208	transcriptional	transcriptional	B-NP	JJ	O	19	NMOD	O
O	O	O	209	214	trans	trans	I-NP	AFX	O	19	NMOD	O
O	O	O	214	215	-	-	I-NP	HYPH	O	19	NMOD	O
O	O	O	215	224	activator	activator	I-NP	NN	O	19	NMOD	O
T3	B-Protein	B-Protein	225	228	Tax	Tax	I-NP	NN	B-protein	20	SUB	B-protein
O	O	O	229	232	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	233	237	been	be	I-VP	VBN	O	20	VC	O
O	O	O	238	250	demonstrated	demonstrate	I-VP	VBN	O	21	VC	O
O	O	O	251	253	to	to	I-VP	TO	O	24	VMOD	O
O	O	O	254	258	have	have	I-VP	VB	O	22	VMOD	O
O	O	O	259	271	transforming	transform	I-VP	VBG	O	26	NMOD	O
O	O	O	272	280	activity	activity	B-NP	NN	O	24	OBJ	O
O	O	O	281	283	in	in	B-PP	IN	O	24	VMOD	O
O	O	O	284	292	multiple	multiple	B-NP	JJ	B-cell_line	30	NMOD	B-cell_line
O	O	O	293	297	cell	cell	I-NP	NN	I-cell_line	30	NMOD	I-cell_line
O	O	O	298	305	culture	culture	I-NP	NN	I-cell_line	35	NMOD	I-cell_line
O	O	O	306	309	and	and	O	CC	O	35	NMOD	O
O	O	O	310	320	transgenic	transgenic	B-NP	JJ	O	35	NMOD	O
O	O	O	320	321	-	-	I-NP	HYPH	O	35	NMOD	O
O	O	O	321	326	mouse	mouse	I-NP	NN	O	35	NMOD	O
O	O	O	327	333	models	model	I-NP	NNS	O	27	PMOD	O
O	O	O	333	334	.	.	O	.	O	20	P	O

O	O	O	335	337	In	In	B-PP	IN	O	38	VMOD	O
O	O	O	338	346	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	O	347	349	to	to	B-PP	TO	O	2	NMOD	O
O	O	O	350	360	activating	activate	B-VP	VBG	O	3	PMOD	O
O	O	O	361	374	transcription	transcription	B-NP	NN	O	4	OBJ	O
O	O	O	375	379	from	from	B-PP	IN	O	5	NMOD	O
O	O	O	380	383	the	the	B-NP	DT	O	11	NMOD	O
T9	B-Entity	B-Entity	384	389	viral	viral	I-NP	JJ	B-DNA	11	NMOD	B-DNA
T9	I-Entity	I-Entity	390	394	long	long	I-NP	JJ	I-DNA	11	NMOD	I-DNA
T9	I-Entity	I-Entity	395	403	terminal	terminal	I-NP	JJ	I-DNA	11	NMOD	I-DNA
T9	I-Entity	I-Entity	404	410	repeat	repeat	I-NP	NN	I-DNA	6	PMOD	I-DNA
O	O	O	411	412	(	(	O	(	O	14	DEP	O
T10	B-Entity	B-Entity	412	415	LTR	LTR	B-NP	NN	B-DNA	14	DEP	B-DNA
O	O	O	415	416	)	)	O	)	O	11	NMOD	O
O	O	O	417	424	through	through	B-PP	IN	O	4	VMOD	O
O	O	O	425	428	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	429	435	cyclic	cyclic	I-NP	JJ	B-protein	32	NMOD	B-protein
O	O	O	436	439	AMP	AMP	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	O	440	448	response	response	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	O	449	456	element	element	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	O	457	464	binding	binding	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	O	465	472	protein	protein	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	O	472	473	/	/	B-NP	SYM	O	32	P	O
O	O	O	473	483	activating	activate	B-VP	VBG	O	26	NMOD	O
O	O	O	484	497	transcription	transcription	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	O	498	504	factor	factor	I-NP	NN	I-protein	32	NMOD	I-protein
O	O	O	505	506	(	(	O	(	O	31	DEP	O
O	O	O	506	510	CREB	CREB	B-NP	NN	B-protein	30	NMOD	B-protein
O	O	O	510	511	/	/	B-NP	SYM	O	30	NMOD	O
O	O	O	511	514	ATF	ATF	I-NP	NN	O	31	DEP	O
O	O	O	514	515	)	)	O	)	O	26	NMOD	O
O	O	O	516	522	family	family	B-NP	NN	O	15	PMOD	O
O	O	O	523	525	of	of	B-PP	IN	O	32	NMOD	O
O	O	O	526	539	transcription	transcription	B-NP	NN	B-protein	35	NMOD	B-protein
O	O	O	540	547	factors	factor	I-NP	NNS	I-protein	33	PMOD	I-protein
O	O	O	547	548	,	,	O	,	O	38	P	O
T4	B-Protein	B-Protein	549	552	Tax	Tax	B-NP	NN	B-protein	38	SUB	B-protein
O	O	O	553	562	activates	activate	B-VP	VBZ	O	0	ROOT	O
O	O	O	563	566	the	the	B-NP	DT	O	40	NMOD	O
O	O	O	567	577	expression	expression	I-NP	NN	O	38	OBJ	O
O	O	O	578	580	of	of	B-PP	IN	O	40	NMOD	O
T11	B-Entity	B-Entity	581	589	multiple	multiple	B-NP	JJ	B-DNA	44	NMOD	B-DNA
T11	I-Entity	I-Entity	590	598	cellular	cellular	I-NP	JJ	I-DNA	44	NMOD	I-DNA
T11	I-Entity	I-Entity	599	608	promoters	promoter	I-NP	NNS	I-DNA	41	PMOD	I-DNA
O	O	O	609	616	through	through	B-PP	IN	O	38	VMOD	O
O	O	O	617	620	the	the	B-NP	DT	O	50	NMOD	O
T12	B-Entity	B-Entity	621	623	NF	NF	I-NP	NN	B-protein	49	NMOD	B-protein
T12	I-Entity	I-Entity	623	624	-	-	B-NP	HYPH	I-protein	49	NMOD	I-protein
T12	I-Entity	I-Entity	624	630	kappaB	kappaB	I-NP	NN	I-protein	50	NMOD	I-protein
O	O	O	631	638	pathway	pathway	I-NP	NN	O	45	PMOD	O
O	O	O	639	641	of	of	B-PP	IN	O	50	NMOD	O
O	O	O	642	657	transcriptional	transcriptional	B-NP	JJ	O	53	NMOD	O
O	O	O	658	668	activation	activation	I-NP	NN	O	51	PMOD	O
O	O	O	668	669	.	.	O	.	O	38	P	O

O	O	O	670	673	The	The	B-NP	DT	O	3	NMOD	O
T5	B-Protein	B-Protein	674	677	Tax	Tax	I-NP	NN	B-protein	3	NMOD	B-protein
O	O	O	678	685	mutants	mutant	I-NP	NNS	I-protein	6	NMOD	I-protein
O	O	O	686	689	M22	M22	I-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	690	693	and	and	I-NP	CC	O	6	NMOD	O
O	O	O	694	697	M47	M47	I-NP	NN	B-protein	7	SUB	B-protein
O	O	O	698	702	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	703	713	previously	previously	I-VP	RB	O	7	VMOD	O
O	O	O	714	718	been	be	I-VP	VBN	O	7	VC	O
O	O	O	719	731	demonstrated	demonstrate	I-VP	VBN	O	9	VC	O
O	O	O	732	734	to	to	B-VP	TO	O	13	VMOD	O
O	O	O	735	746	selectively	selectively	I-VP	RB	O	13	VMOD	O
O	O	O	747	755	abrogate	abrogate	I-VP	VB	O	10	VMOD	O
O	O	O	756	759	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	760	767	ability	ability	I-NP	NN	O	13	OBJ	O
O	O	O	768	770	of	of	B-PP	IN	O	15	NMOD	O
T6	B-Protein	B-Protein	771	774	Tax	Tax	B-NP	NN	B-protein	16	PMOD	B-protein
O	O	O	775	777	to	to	B-VP	TO	O	19	VMOD	O
O	O	O	778	786	activate	activate	I-VP	VB	O	15	NMOD	O
O	O	O	787	800	transcription	transcription	B-NP	NN	O	19	OBJ	O
O	O	O	801	808	through	through	B-PP	IN	O	19	VMOD	O
O	O	O	809	812	the	the	B-NP	DT	O	25	NMOD	O
T13	B-Entity	B-Entity	813	815	NF	NF	I-NP	NN	B-protein	25	NMOD	B-protein
T13	I-Entity	I-Entity	815	816	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
T13	I-Entity	I-Entity	816	822	kappaB	kappaB	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	823	825	or	or	I-NP	CC	O	30	NMOD	O
O	O	O	826	830	CREB	CREB	I-NP	NN	B-protein	30	NMOD	B-protein
O	O	O	830	831	/	/	O	SYM	O	30	NMOD	O
O	O	O	831	834	ATF	ATF	B-NP	NN	B-protein	30	NMOD	B-protein
O	O	O	835	842	pathway	pathway	I-NP	NN	O	21	PMOD	O
O	O	O	842	843	,	,	O	,	O	19	P	O
O	O	O	844	856	respectively	respectively	B-ADVP	RB	O	19	VMOD	O
O	O	O	856	857	.	.	O	.	O	7	P	O

O	O	O	858	863	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	864	873	mutations	mutation	I-NP	NNS	O	3	SUB	O
O	O	O	874	878	were	be	B-VP	VBD	O	28	VMOD	O
O	O	O	879	889	introduced	introduce	I-VP	VBN	O	3	VC	O
O	O	O	890	892	in	in	B-PP	IN	O	4	VMOD	O
O	O	O	893	896	the	the	B-NP	DT	O	8	NMOD	O
T7	B-Protein	B-Protein	897	900	tax	tax	I-NP	NN	B-DNA	8	NMOD	B-DNA
O	O	O	901	905	gene	gene	I-NP	NN	I-DNA	5	PMOD	I-DNA
O	O	O	906	908	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	909	912	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	913	916	ACH	ACH	I-NP	NN	B-DNA	14	NMOD	B-DNA
O	O	O	917	927	functional	functional	I-NP	JJ	I-DNA	14	NMOD	I-DNA
O	O	O	928	937	molecular	molecular	I-NP	JJ	I-DNA	14	NMOD	I-DNA
O	O	O	938	943	clone	clone	I-NP	NN	I-DNA	9	PMOD	I-DNA
O	O	O	944	946	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	947	951	HTLV	HTLV	B-NP	NN	B-protein	15	PMOD	B-protein
O	O	O	951	952	-	-	B-NP	HYPH	O	16	P	O
O	O	O	952	953	1	1	I-NP	CD	O	16	NMOD	O
O	O	O	953	954	,	,	O	,	O	21	P	O
O	O	O	955	958	and	and	O	CC	O	21	NMOD	O
O	O	O	959	964	virus	virus	B-NP	NN	O	28	SUB	O
O	O	O	965	973	produced	produce	B-VP	VBN	O	21	NMOD	O
O	O	O	974	978	from	from	B-PP	IN	O	22	VMOD	O
O	O	O	979	982	the	the	B-NP	DT	O	27	NMOD	O
T14	B-Entity	B-Entity	983	989	mutant	mutant	I-NP	JJ	B-DNA	27	NMOD	B-DNA
T14	I-Entity	I-Entity	990	993	ACH	ACH	I-NP	NN	I-DNA	27	NMOD	I-DNA
T14	I-Entity	I-Entity	994	1000	clones	clone	I-NP	NNS	I-DNA	23	PMOD	I-DNA
O	O	O	1001	1004	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1005	1013	examined	examine	I-VP	VBN	O	28	VC	O
O	O	O	1014	1017	for	for	B-PP	IN	O	29	VMOD	O
O	O	O	1018	1021	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	1022	1029	ability	ability	I-NP	NN	O	30	PMOD	O
O	O	O	1030	1032	to	to	B-VP	TO	O	34	VMOD	O
O	O	O	1033	1042	replicate	replicate	I-VP	VB	O	32	NMOD	O
O	O	O	1043	1046	and	and	I-VP	CC	O	34	VMOD	O
O	O	O	1047	1058	immortalize	immortalize	I-VP	VB	O	34	VMOD	O
O	O	O	1059	1066	primary	primary	B-NP	JJ	B-cell_type	39	NMOD	B-cell_type
O	O	O	1067	1072	human	human	I-NP	JJ	I-cell_type	39	NMOD	I-cell_type
O	O	O	1073	1084	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	34	VMOD	I-cell_type
O	O	O	1084	1085	.	.	O	.	O	28	P	O

O	O	O	1086	1091	While	While	B-SBAR	IN	O	22	VMOD	O
O	O	O	1092	1097	virus	virus	B-NP	NN	O	11	SUB	O
O	O	O	1098	1105	derived	derive	B-VP	VBN	O	2	NMOD	O
O	O	O	1106	1110	from	from	B-PP	IN	O	3	VMOD	O
O	O	O	1111	1114	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	1115	1120	clone	clone	I-NP	NN	O	4	PMOD	O
O	O	O	1121	1131	containing	contain	B-VP	VBG	O	6	NMOD	O
O	O	O	1132	1135	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	1136	1139	M47	M47	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	O	1140	1148	mutation	mutation	I-NP	NN	O	7	OBJ	O
O	O	O	1149	1157	retained	retain	B-VP	VBD	O	1	SBAR	O
O	O	O	1158	1161	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	1162	1169	ability	ability	I-NP	NN	O	11	OBJ	O
O	O	O	1170	1172	to	to	B-VP	TO	O	15	VMOD	O
O	O	O	1173	1184	immortalize	immortalize	I-VP	VB	O	13	NMOD	O
O	O	O	1185	1186	T	T	B-NP	NN	B-cell_type	17	NMOD	B-cell_type
O	O	O	1187	1198	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	15	OBJ	I-cell_type
O	O	O	1198	1199	,	,	O	,	O	22	P	O
O	O	O	1200	1203	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	1204	1207	M22	M22	I-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	1208	1214	mutant	mutant	I-NP	NN	O	22	SUB	O
O	O	O	1215	1219	lost	lose	B-VP	VBD	O	0	ROOT	O
O	O	O	1220	1223	the	the	B-NP	DT	O	24	NMOD	O
O	O	O	1224	1231	ability	ability	I-NP	NN	O	22	OBJ	O
O	O	O	1232	1234	to	to	B-VP	TO	O	26	VMOD	O
O	O	O	1235	1246	immortalize	immortalize	I-VP	VB	O	24	NMOD	O
O	O	O	1247	1255	infected	infected	B-NP	JJ	B-cell_type	28	NMOD	B-cell_type
O	O	O	1256	1261	cells	cell	I-NP	NNS	I-cell_type	26	OBJ	I-cell_type
O	O	O	1261	1262	.	.	O	.	O	22	P	O

O	O	O	1263	1268	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1269	1276	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1277	1285	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	1286	1290	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1291	1301	activation	activation	B-NP	NN	O	14	SUB	O
O	O	O	1302	1304	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	1305	1308	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	1309	1313	CREB	CREB	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	O	1313	1314	/	/	B-NP	SYM	O	11	NMOD	O
O	O	O	1314	1317	ATF	ATF	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	O	1318	1325	pathway	pathway	I-NP	NN	O	6	PMOD	O
O	O	O	1326	1328	by	by	B-PP	IN	O	5	NMOD	O
T8	B-Protein	B-Protein	1329	1332	Tax	Tax	B-NP	NN	B-protein	12	PMOD	B-protein
O	O	O	1333	1335	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	O	1336	1347	dispensable	dispensable	B-ADJP	JJ	O	14	PRD	O
O	O	O	1348	1351	for	for	B-PP	IN	O	15	AMOD	O
O	O	O	1352	1355	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	1356	1371	immortalization	immortalization	I-NP	NN	O	16	PMOD	O
O	O	O	1372	1374	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	1375	1376	T	T	B-NP	NN	B-cell_type	21	NMOD	B-cell_type
O	O	O	1377	1382	cells	cell	I-NP	NNS	I-cell_type	19	PMOD	I-cell_type
O	O	O	1383	1385	by	by	B-PP	IN	O	18	NMOD	O
O	O	O	1386	1390	HTLV	HTLV	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	O	1390	1391	-	-	O	HYPH	O	25	P	O
O	O	O	1391	1392	1	1	B-NP	CD	O	22	PMOD	O
O	O	O	1392	1393	,	,	O	,	O	14	P	O
O	O	O	1394	1401	whereas	whereas	B-PP	IN	O	14	VMOD	O
O	O	O	1402	1412	activation	activation	B-NP	NN	O	35	SUB	O
O	O	O	1413	1415	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	1416	1419	the	the	B-NP	DT	O	34	NMOD	O
T15	B-Entity	B-Entity	1420	1422	NF	NF	I-NP	NN	B-protein	34	NMOD	B-protein
T15	I-Entity	I-Entity	1422	1423	-	-	B-NP	HYPH	I-protein	34	NMOD	I-protein
T15	I-Entity	I-Entity	1423	1429	kappaB	kappaB	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	O	1430	1437	pathway	pathway	I-NP	NN	O	29	PMOD	O
O	O	O	1438	1441	may	may	B-VP	MD	O	27	SBAR	O
O	O	O	1442	1444	be	be	I-VP	VB	O	35	VC	O
O	O	O	1445	1453	critical	critical	B-ADJP	JJ	O	36	PRD	O
O	O	O	1453	1454	.	.	O	.	O	3	P	O
